Search - tctmd.com

Displaying 901 - 920 of 1676

Sort: Relevancy | Date

News Daily News

TAVR for Bicuspid Aortic Valve Stenosis Feasible, but Associated With Higher Rate of Permanent Pacemaker Implantation

Michael O'Riordan

July 05, 2016

News Daily News

La Intervención TAVR para el Manejo de la Estenosis de la Válvula Aórtica Bicúspide es Viable pero se asocia a un Índice Más Alto de Implantación de Marcapasos Permanente

Michael O'Riordan

July 05, 2016

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2016

Shelley Wood

July 01, 2016

News Features

Clots Found in the Left Atrial Appendage: A Big Deal for TAVR?

Todd Neale

June 27, 2016

News Industry News

BioVentrix Receives CE Marking Certification for Revivent TC™, the First Minimally Invasive Heart Failure Treatment to Restore the Left Ventricle

June 27, 2016

News Daily News

Persistent Low-Flow Aortic Stenosis After TAVR Linked With Higher 1-Year Mortality

Michael O'Riordan

June 23, 2016

News Daily News

La Estenosis Aórtica Persistente de Bajo Flujo Post-TAVR se asocia a una Mortalidad Más Alta al cabo de 1 Año

Michael O'Riordan

June 23, 2016

News Conference News TVT 2016

When Is Sick Too Sick for TAVR? Physicians Grapple With Identifying Futile Care

Michael O'Riordan

June 20, 2016

News Conference News TVT 2016

Valve Degeneration Data Dearth Spurs Calls for Universal Definitions and Clinical Guidance

Shelley Wood

June 20, 2016

News Conference News TVT 2016

Teenage TAVR: Should Practice Forge on While Guidelines Grow Up?

Michael O'Riordan

June 20, 2016

News Conference News TVT 2016

Not All Valves With Leaflet Thickening Develop Mobility Problems, Repeat 4D CT Shows in SAVORY

Michael O'Riordan

June 18, 2016

Presentation TVT 2016

New TAVR Risk Models (eg, From TVT and FRANCE 2 Registries): Development, Clinical Validation, Current Use, and Future Directions

Presenter: David J. Cohen

June 17, 2016

Presentation TVT 2016

Conduction Disturbances and Arrhythmias After TAVR: Remaining Issues and Best Clinical Practices

Presenter: Josep Rodés-Cabau

June 17, 2016

Presentation TVT 2016

TVT 1176: Compassionate Use of a Self-Expanding Aortic Valve Bioprosthesis in Severe Aortic Regurgitation Without Aortic Stenosis or Annular Calcification

Presenter: Mehul Patel, MD

June 17, 2016

Presentation TVT 2016

Clinical Experiences and Echo Data from Rouen

Presenter: Helene Eltchaninoff

June 17, 2016

Presentation TVT 2016

Combined TAVR and Left Atrial Appendage Closure in AS Patients With Atrial Fibrillation: Case Selection, Procedural Consideration, and Clinical Outcomes

Presenter: Fabian Nietlispach

June 17, 2016

Presentation TVT 2016

Complexities of Managing AS Patients With Atrial Fibrillation After TAVR

Presenter: Samir R. Kapadia

June 17, 2016

Presentation TVT 2016

Is There a Role For MitraClip After TAVR in Patients With Significant Residual MR?

Presenter: Brij Maini

June 17, 2016

Presentation TVT 2016

Management Decisions in the Patient With Severe AS and Mitral Regurgitation

Presenter: Marco Barbanti

June 17, 2016

Presentation TVT 2016

Introducing the UNLOAD TAVR Study: Potential Clinical Benefits of TAVR in Patients With Moderate AS and Reduced-EF Heart Failure

Presenter: Nicolas M. Van Mieghem

June 17, 2016

Advertisement

TAVR for Bicuspid Aortic Valve Stenosis Feasible, but Associated With Higher Rate of Permanent Pacemaker Implantation

La Intervención TAVR para el Manejo de la Estenosis de la Válvula Aórtica Bicúspide es Viable pero se asocia a un Índice Más Alto de Implantación de Marcapasos Permanente

TCTMD’s Top 10 Most Popular Stories for June 2016

Clots Found in the Left Atrial Appendage: A Big Deal for TAVR?

BioVentrix Receives CE Marking Certification for Revivent TC™, the First Minimally Invasive Heart Failure Treatment to Restore the Left Ventricle

Persistent Low-Flow Aortic Stenosis After TAVR Linked With Higher 1-Year Mortality

La Estenosis Aórtica Persistente de Bajo Flujo Post-TAVR se asocia a una Mortalidad Más Alta al cabo de 1 Año

When Is Sick Too Sick for TAVR? Physicians Grapple With Identifying Futile Care

Valve Degeneration Data Dearth Spurs Calls for Universal Definitions and Clinical Guidance

Teenage TAVR: Should Practice Forge on While Guidelines Grow Up?

Not All Valves With Leaflet Thickening Develop Mobility Problems, Repeat 4D CT Shows in SAVORY

New TAVR Risk Models (eg, From TVT and FRANCE 2 Registries): Development, Clinical Validation, Current Use, and Future Directions

Conduction Disturbances and Arrhythmias After TAVR: Remaining Issues and Best Clinical Practices

TVT 1176: Compassionate Use of a Self-Expanding Aortic Valve Bioprosthesis in Severe Aortic Regurgitation Without Aortic Stenosis or Annular Calcification

Clinical Experiences and Echo Data from Rouen

Combined TAVR and Left Atrial Appendage Closure in AS Patients With Atrial Fibrillation: Case Selection, Procedural Consideration, and Clinical Outcomes

Complexities of Managing AS Patients With Atrial Fibrillation After TAVR

Is There a Role For MitraClip After TAVR in Patients With Significant Residual MR?

Management Decisions in the Patient With Severe AS and Mitral Regurgitation

Introducing the UNLOAD TAVR Study: Potential Clinical Benefits of TAVR in Patients With Moderate AS and Reduced-EF Heart Failure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content